490 related articles for article (PubMed ID: 24019185)
1. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis.
Carey EJ; Iyer VN; Nelson DR; Nguyen JH; Krowka MJ
Liver Transpl; 2013 Dec; 19(12):1370-6. PubMed ID: 24019185
[TBL] [Abstract][Full Text] [Related]
2. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
Banga A; Gildea T; Rajeswaran J; Rokadia H; Blackstone EH; Stoller JK
Am J Respir Crit Care Med; 2014 Aug; 190(3):274-81. PubMed ID: 25003824
[TBL] [Abstract][Full Text] [Related]
3. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
4. Alpha-1-antitrypsin deficiency: outcomes after liver transplantation.
Kemmer N; Kaiser T; Zacharias V; Neff GW
Transplant Proc; 2008 Jun; 40(5):1492-4. PubMed ID: 18589136
[TBL] [Abstract][Full Text] [Related]
5. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.
Sitkauskiene B; Serapinas D; Blanco I; Fernández-Bustillo E; Janciauskiene S; Sakalauskas R
Respir Med; 2008 Nov; 102(11):1654-8. PubMed ID: 18722101
[TBL] [Abstract][Full Text] [Related]
6. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
[TBL] [Abstract][Full Text] [Related]
7. Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals.
Lara B; Miravitlles M
COPD; 2015 May; 12 Suppl 1():27-31. PubMed ID: 25938288
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group.
Turino GM; Barker AF; Brantly ML; Cohen AB; Connelly RP; Crystal RG; Eden E; Schluchter MD; Stoller JK
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1718-25. PubMed ID: 8970361
[TBL] [Abstract][Full Text] [Related]
9. Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency.
Stoller JK; Gildea TR; Ries AL; Meli YM; Karafa MT;
Ann Thorac Surg; 2007 Jan; 83(1):241-51. PubMed ID: 17184672
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
[TBL] [Abstract][Full Text] [Related]
11. Effect of liver transplant on pulmonary functions in adult patients with alpha 1 antitrypsin deficiency: 7 cases.
Jain AB; Patil V; Sheikh B; Apostolakos M; Ryan C; Kashyap R; Orloff M
Exp Clin Transplant; 2010 Mar; 8(1):4-8. PubMed ID: 20199364
[TBL] [Abstract][Full Text] [Related]
12. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma.
van Veen IH; ten Brinke A; van der Linden AC; Rabe KF; Bel EH
Respir Med; 2006 Sep; 100(9):1534-9. PubMed ID: 16476537
[TBL] [Abstract][Full Text] [Related]
13. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
[No Abstract] [Full Text] [Related]
14. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals.
Dahl M; Nordestgaard BG; Lange P; Vestbo J; Tybjaerg-Hansen A
Clin Chem; 2001 Jan; 47(1):56-62. PubMed ID: 11148177
[TBL] [Abstract][Full Text] [Related]
15. Ethnic differences in alpha-1 antitrypsin deficiency in the United States of America.
de Serres FJ; Blanco I; Fernández-Bustillo E
Ther Adv Respir Dis; 2010 Apr; 4(2):63-70. PubMed ID: 20435667
[TBL] [Abstract][Full Text] [Related]
16. Performance of enhanced liver fibrosis plasma markers in asymptomatic individuals with ZZ α1-antitrypsin deficiency.
Janciauskiene S; Wallmark A; Piitulainen E; Köhnlein T; Welte T; Sveger T
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):716-20. PubMed ID: 21617532
[TBL] [Abstract][Full Text] [Related]
17. Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis.
Al-Jameil N; Hassan AA; Buhairan A; Hassanato R; Isac SR; Al-Otaiby M; Al-Maarik B; Al-Ajeyan I
Medicine (Baltimore); 2017 Feb; 96(6):e6071. PubMed ID: 28178162
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
[TBL] [Abstract][Full Text] [Related]
19. Long term results of liver transplantation for alpha-1 antitrypsin deficiency.
Guillaud O; Jacquemin E; Couchonnal E; Vanlemmens C; Francoz C; Chouik Y; Conti F; Duvoux C; Hilleret MN; Kamar N; Houssel-Debry P; Neau-Cransac M; Pageaux GP; Gonzales E; Ackermann O; Gugenheim J; Lachaux A; Ruiz M; Radenne S; Debray D; Lacaille F; McLin V; Duclos-Vallée JC; Samuel D; Coilly A; Dumortier J
Dig Liver Dis; 2021 May; 53(5):606-611. PubMed ID: 33139195
[TBL] [Abstract][Full Text] [Related]
20. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
Turner AM; Stolk J; Bals R; Lickliter JD; Hamilton J; Christianson DR; Given BD; Burdon JG; Loomba R; Stoller JK; Teckman JH
J Hepatol; 2018 Aug; 69(2):378-384. PubMed ID: 29572094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
